Cita APA (7a ed.)
Li, T., Zhang, T., Dang, Y., Lin, Y., Li, X., & Ling, X. (2026). Trop2-Based Antibody–Drug Conjugates: Emerging Strategy and Progress in Triple-Negative Breast Cancer Therapy. Current Oncology, 31(2), 92-110.
Cita Chicago Style (17a ed.)
Li, Tong, Tao Zhang, Yongxia Dang, Yilin Lin, Xiaotong Li, y Xiaoling Ling. "Trop2-Based Antibody–Drug Conjugates: Emerging Strategy and Progress in Triple-Negative Breast Cancer Therapy." Current Oncology 31, no. 2 (2026): 92-110.
Cita MLA (9a ed.)
Li, Tong, et al. "Trop2-Based Antibody–Drug Conjugates: Emerging Strategy and Progress in Triple-Negative Breast Cancer Therapy." Current Oncology, vol. 31, no. 2, 2026, pp. 92-110.
Precaución: Estas citas no son 100% exactas.